Last Updated: Thursday, September 10, 2015, 08:04
"Decisions are being made to either close or divest some of our manufacturing facilities," a Sun Pharma spokesman said in an emailed statement.
Last Updated: Tuesday, September 1, 2015, 13:01
The company has started the integration of opiates business after completion of the deal, which would strengthen its position in global market and expand its narcotics raw material (NRM) market share.
Last Updated: Saturday, August 29, 2015, 20:22
Indian pharma industry is capable of discovering at least a couple of new drugs in the next 10 years, Sun Pharmaceutical Industries founder and managing director Dilip Shanghvi said today
Last Updated: Friday, August 28, 2015, 19:24
Sun Pharmaceutical Industries on Friday said a class action lawsuit has been filed against its US arm by some former employees following the shut down of a manufacturing unit at Detroit in Michigan.
Last Updated: Tuesday, July 21, 2015, 09:42
Shares in Sun Pharmaceutical Industries slumped 16 percent, heading towards their biggest daily fall ever, after the drugmaker on Monday said it sees 2016 sales flat at best.
Last Updated: Monday, June 1, 2015, 18:19
Shares of Sun Pharmaceutical Industries plunged over 9 percent Monday, wiping out Rs 20,864 crore from its market valuation, after the company's fourth quarter earnings came below market expectations.
Last Updated: Wednesday, April 15, 2015, 19:05
Sun Pharmaceutical Industries has inked a pact with Israel's Technion university to develop anti-cancer drugs.
Last Updated: Wednesday, April 1, 2015, 19:12
Drug major Sun Pharmaceutical Industries has entered into a settlement pact with US-based The Medicines Company for settling the lawsuit filed against it by the later for generic Angiomax.
Last Updated: Sunday, March 8, 2015, 11:08
The combined market valuation of top five Sensex companies rose by Rs 48,822.93 crore last week, where Sun Pharmaceutical Industries emerged as the biggest gainer.
Last Updated: Monday, August 12, 2013, 19:25
The scrip ended the day 6.60 percent higher at Rs 540.55 on the BSE. In the intra-day trade, the stock rallied 8.87 percent to Rs 552.10.
Last Updated: Tuesday, June 4, 2013, 17:04
The approval is for the product in the strengths of 100 mg/ml and 200mg/ml, it added.
Last Updated: Monday, June 3, 2013, 12:15
Sun Pharmaceutical’s share prices fell as much as 2.23 percent on Monday amidst reports that it is in talks to buy Sweden's Meda AB for over $5 billion.
more videos >>
